Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness

ClinicalTrials.gov ID: NCT00632463

Public ClinicalTrials.gov record NCT00632463. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:08 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00632463
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
ADMA Biologics, Inc.
Industry
Enrollment
21 participants

Conditions and interventions

Interventions

  • RI-001 Biological

Biological

Eligibility (public fields only)

Age range
2 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2008
Primary completion
Apr 30, 2010
Completion
Apr 30, 2010
Last update posted
Apr 23, 2013

2008 – 2010

United States locations

U.S. sites
15
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
University of California San Francisco San Francisco California 94143
University of Colorado Health Sciences Center Aurora Colorado 80045
Children's National Medical Center Washington D.C. District of Columbia 20010
All Children's Hospital St. Petersburg Florida 33701
Rush University Medical Center Chicago Illinois 60612
Johns Hopkins Medical Center Baltimore Maryland 21205
New England Medical Center Boston Massachusetts 02111
Hackensack University Medical Center Hackensack New Jersey 07601
Schneider Children's Hospital New Hyde Park New York 11040
University of Rochester Medical Center Rochester New York 14642
Oregon Health and Science University Portland Oregon 97239
Children's Medical Center of Dallas Dallas Texas 75235
Cook Children's Medical Center Fort Worth Texas 76104
Seattle Children's Hospital and Regional Medical Center Seattle Washington 98105
Fred Hutchinson Cancer Research Center Seattle Washington 98109

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00632463, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00632463 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →